Pentosan Polysulphate
Other300mg 3 times a day
NCT Number: NCT05744908
To examine the relationship between symptoms and quality of life before and after oral pentosan polysulfate (PPS) treatment in cases diagnosed with interstitial cystitis/painful bladder syndrome (IC/BPS).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Basri Cakiroglu, Istanbul, Turkey (Türkiye)
Demographic characteristics, medical history, clinical conditions, and laboratory and cystoscopic data of patients who applied to our clinic between January 2018 and December 2021 and were diagnosed with IC/BPS were retrospectively analyzed. Adult male and female patients with IC/BPS who received 300 mg/day PPS at least six months ago with complaints of pain, urge, frequency, and nocturia not associated with urinary tract infection were included in the study. In addition, pre- and post-treatment symptoms, ICSI scores, quality of life (scored between 1-4), and satisfaction were compared.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
300mg 3 times a day
Time frame: Three months
0.3 over 3 mm 1 under 3 mm,
Time frame: Three months
1 if symptoms improved, 0 if not
Hisar Intercontinental Hospital
Other
Retrospective Evaluation of the Effectiveness of Oral Pentosan Polysulfate Treatment in the Improvement of Chronic Interstitial Cystitis Symptoms
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04275297
Bladder Pain Syndrome, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT04540887
Bladder Pain Syndrome, Chronic Interstitial Cystitis
Winston-Salem, North Carolina, United States
View Trial DetailsNCT02331472
Chronic Interstitial Cystitis, Cystitis
Seoul, South Korea
View Trial DetailsNCT01879683
Chronic Interstitial Cystitis, Cystitis
Daytona Beach, Florida, United States
View Trial Details